GILD stock verdict - Value
GILD
Gilead Sciences, Inc.
VALUEHealthcare
$129.31
Buy
$129.31
Heavy$114.35Buy$138.85Fair$163.35Exit$179.69
FUNDAMENTAL63
TECHNICAL57
TRUST SCORE
100High
confidence in this read — data completeness, earnings quality & coverage
Neutral · EMA20 130.8 · EMA50 130.85 · EMA200 128.86 · RSI 47.4 · MACD below signal
PROS
- Trades 21% below the model's fair value ($163.35)
- Reasonable forward P/E of 13.4× on analyst estimates
- Strong return on equity of 39.9% (TTM)
- TTM EPS grew 54.5% year-over-year
- Converts 34% of revenue into free cash flow
CONS
No red flags detected.
✳ Pros and cons are machine-generated from the latest fundamentals and technicals.
EARNINGS QUALITY · we check the accounting so you don't have to
✓Operating cash flow is 118% of net income — profit is backed by real cash
✓Low accruals — reported profit tracks the cash actually generated
✓Receivables growing in line with sales
SECTOR PEERS
Analysis as of 2026-07-27 · price live, fundamentals from latest filings
FAQ
Why is GILD rated Value?
GILD (Gilead Sciences, Inc.) is rated Value because the model combines fundamentals, price action, and earnings-quality checks. The current signal is Buy. Trades 21% below the model's fair value ($163.35) and Reasonable forward P/E of 13.4× on analyst estimates
Is GILD overvalued right now?
GILD is trading at $129.31 versus an estimated fair value of $163.35. That puts the stock in value territory on this framework. The page shows the specific downside checks behind that call.
What should I watch before acting on GILD?
Watch the trust score of 100, the earnings-quality checks, and any red flags. The page includes the key cautions and a plain-English summary.